Assertio Holdings (ASRT) Depreciation & Amortization - Total (2019 - 2026)

Assertio Holdings' (ASRT) quarterly Depreciation & Amortization - Total came in at $100000.0 in Q1 2026, little changed year-on-year from $100000.0 in Q1 2025, and little changed quarter-over-quarter from $100000.0 in Q3 2025.

Assertio Holdings (ASRT) Depreciation & Amortization - Total (2019 - 2026) Analysis & Trends

Assertio Holdings has disclosed Depreciation & Amortization - Total across 8 years of filings, most recently posting $100000.0 for Q1 2026.

  • Depreciation & Amortization - Total for Q1 2026 came in at $100000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $300000.0 (down 25.0% YoY), and the FY2025 annual result was $100000.0, down 50.0% from the prior year.
  • Depreciation & Amortization - Total came in at $100000.0 for Q1 2026 at Assertio Holdings, roughly flat from $100000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization - Total ranged from a high of $200000.0 in Q1 2022 to a low of $100000.0 in Q4 2023.
  • The 5-year median for Depreciation & Amortization - Total is $100000.0 (2023), against an average of $143750.0.
  • Across the five-year window, Depreciation & Amortization - Total changed 0.0% in 2022 and plunged 50.0% in 2023, its largest moves.
  • Assertio Holdings' Depreciation & Amortization - Total stood at $200000.0 in 2022, then slumped by 50.0% to $100000.0 in 2023, then changed by 0.0% to $100000.0 in 2024, then changed by 0.0% to $100000.0 in 2025, then changed by 0.0% to $100000.0 in 2026.
  • The last three Depreciation & Amortization - Total figures came in at $100000.0 (Q1 2026), $100000.0 (Q3 2025), and $100000.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Tot) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn -
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -
10 Assertio Holdings 150.94 Mn 79.37 Mn 7.22 Mn 100,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 100,000.00
Sep 30, 2025 100,000.00
Jun 30, 2025 100,000.00
Mar 31, 2025 100,000.00
Dec 31, 2024 100,000.00
Sep 30, 2024 100,000.00
Jun 30, 2024 100,000.00
Mar 31, 2024 100,000.00
Dec 31, 2023 100,000.00
Sep 30, 2023 200,000.00
Jun 30, 2023 200,000.00
Mar 31, 2023 200,000.00
Dec 31, 2022 200,000.00
Sep 30, 2022 200,000.00
Jun 30, 2022 200,000.00
Mar 31, 2022 200,000.00
Dec 31, 2021 200,000.00
Sep 30, 2021 200,000.00
Jun 30, 2021 300,000.00
Mar 31, 2021 300,000.00